MedPath

I-gel Versus Classic-Laryngeal Mask Airway (C-LMA) as a Conduit for Tracheal Intubation Using Ventilating Bougie

Not Applicable
Completed
Conditions
Intubation; Difficult
Registration Number
NCT02566135
Lead Sponsor
Medical College Baroda
Brief Summary

Supraglottic Airway devices(SGAs) like I-Gel and C-LMA ( classic laryngeal mask airway ) have been used as a conduit for tracheal intubation using ventilating bougie. General Anaesthesia with tracheal intubation is one of the technique for giving anaesthesia. Tracheal intubation may become difficult sometimes and endangers patients life. Using SGAs as a conduit for tracheal intubation helps in securing airway. This will be further facilitated by using ventilating bougie, as it maintains oxygenation.

Detailed Description

SGAs have been used as a conduit for tracheal intubation using ventilating bougie. Patients were anaesthetised with intravenous induction agent, non-depolarising muscle relaxant and then SGAs were inserted. Two groups were compared. In group I : I-gel was inserted, its position was confirmed and then ventilating bougie was inserted through it. It's position was confirmed, then I-gel was removed , Endotracheal tube was railroaded over ventilating bougie and it's position was confirmed. In group C : C-LMA was inserted, its position was confirmed and then ventilating bougie was inserted through it. It's position was confirmed, then C-LMA was removed , Endotracheal tube was railroaded over ventilating bougie and it's position was confirmed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
58
Inclusion Criteria
  • age 18 to 60 years
  • Gender : either sex
  • American society of Anaesthesiologist's Physical Status (ASAPS) I and II
  • Patients posted for surgery requiring general anaesthesia and endotracheal intubation.
Exclusion Criteria
  • age <18 years and > 60 years
  • ASAPS III or IV
  • Obesity body mass index >25
  • Patients with mouth opening <2cms
  • Patients with Malampatti grade III and IV
  • Patients having history of gastro-esophageal reflux disease
  • Patients with history of inadequate fasting
  • Patients with known or anticipated difficult tracheal intubation or face-mask ventilation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Number of Attempts for I-gel or Classic-LMA Insertions60 seconds
Number of Attempts for Ventilating Bougie Insertions Through I-gel or C-LMA45 seconds
Number of Attempts for Railroading of Endotracheal Tube Over Ventilating Bougie30 seconds
Time of Insertion5 minutes
Total Intubation Time5 minutes
Secondary Outcome Measures
NameTimeMethod
Diastolic Blood Pressure25 minutes

Diastolic blood pressure measured at following time intervals.

1. Base line

2. After Dexmedetomidine injection

3. After Induction

4. Supraglottic airway insertion

5. Ventilating bougie insertion

6. ETT insertion

7. 3 minute after ETT insertion

8. 5 minute after ETT insertion

9. 7 minute after ETT insertion

10. 10 minutes after ETT insertion

11. 15 minute after ETT insertion The study period was upto 15 minutes. thereafter study ends.

Heart Rate25 minutes

Heart rate to observe at the following time intervals.

1. Base line

2. After induction

3. After dexmedetomidine injection

4. Supraglottic airway insertion

5. Ventilating bougie insertion

6. ETT insertion

7. 3minute after ETT insertion

8. 5 minute after ETT insertion

9. 7 minute after ETT insertion

10. 10 minute after ETT insertion

11. 15 minute after ETT insertion Study period is upto 15 minutes, thereafter the study ends here.

Systolic Blood Pressure25 minutes

Systolic blood pressure measured at following time intervals.

1. Base line

2. After Dexmedetomidine injection

3. After induction of anaesthesia

4. Supraglottic airway insertion

5. Ventilating bougie insertion

6. ETT insertion

7. 3 minute after ETT insertion

8. 5 minute after ETT insertion

9. 7 minute after ETT insertion

10. 10 minute after ETT insertion

11. 15 minute after ETT insertion. The study period was upto 15 minutes and thereafter the study ends.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.